Año: 2022
Journal Impact Factor (JIF): 2,3
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
PHARMACOLOGY & PHARMACY | SCIE | 200/278 | Q3 | T3 | D8 |
PSYCHIATRY | SCIE | 115/155 | Q3 | T3 | D8 |
PSYCHOLOGY, BIOLOGICAL | SSCI | 8/14 | Q3 | T2 | D6 |
PSYCHOLOGY, CLINICAL | SSCI | 79/131 | Q3 | T2 | D6 |
Año: 2022
Journal Citation Indicator (JCI): 0,820
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
PHARMACOLOGY & PHARMACY | 125/366 | Q2 | T2 | D4 | 65,98 |
PSYCHIATRY | 106/264 | Q2 | T2 | D4 | 60,04 |
PSYCHOLOGY, BIOLOGICAL | 6/18 | Q2 | T1 | D4 | 69,44 |
PSYCHOLOGY, CLINICAL | 79/180 | Q2 | T2 | D5 | 56,39 |
Año:
2022
CiteScore:
4,300
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Pharmacology (medical) | 114/260 | Q2 | T2 | D5 |
Psychiatry and Mental Health | 216/531 | Q2 | T2 | D5 |
Pharmacology | 160/301 | Q3 | T2 | D6 |
SJR año:
2023
Factor de Impacto:
0,827
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Pharmacology (medical) | 75/276 | Q2 | T1 | D3 |
Pharmacology | 98/323 | Q2 | T1 | D4 |
Psychiatry and Mental Health | 211/578 | Q2 | T2 | D4 |
Agencia | Código de Proyecto |
---|---|
Spanish Government Delegation for the National Plan on Drugs | 2020I003 |
# | Autor | Afiliación |
---|---|---|
1 | University of Oviedo (Spain) | |
2 | Martínez-Loredo, V | University of Zaragoza (Spain) |
3 | Postigo, A | University of Oviedo (Spain) |
4 | Yoon, JH | The University of Texas Health Science Center at Houston Louis A Faillace MD Department of Psychiatry and Behavioral Sciences (USA) |